Portal but not peripheral serum levels of interleukin 6 could interfere with glucose metabolism in patients with pancreatic cancer. - Fogar,P.; Basso,D.; Pasquali,C.; Piva,MG.; Brigato,L.; Paoli,M De.; Galeotti,F.; Corsini,A.; Plebani,M. (Clin Chim Acta, 1998)